Polski
3D Printing, AI vs. Opioids, and At-Home Dressings - Three News Stories Reshaping Dental Practices
This week in the dental and aesthetic medicine industry shows just how deeply technology and medicine intertwine in everyday practice. A Lithuanian manufacturer is expanding its range of certified 3D printing materials, Harvard researchers are testing AI designed to help combat opioid misuse, and the FDA has approved a periodontal dressing for at-home use for the first time. Let's take a closer look at what's changing.
01 · 3D Printing
Lithuania Bets on Certified 3D Printing Resins
The Lithuanian company AmeraLabs has launched three new 3D printing materials in the CE Class I category [1]. TRY-23 is designed for making try-in dentures, SGR-28 is a resin intended for surgical guides, and CIT-25 is suited for printing custom impression trays. All three meet the EN ISO 10993-1 standard, meaning they pass the standard biocompatibility tests required for medical devices that come into contact with patient tissue. For dental labs, this is a sign that the catalog of safe, proven resins keeps growing, and material choice no longer has to be limited to a handful of global brands.
Importantly for labs and clinics, the materials are compatible with popular LCD/LED and DLP printers from various manufacturers. This means there's no need to invest in a specific, closed hardware ecosystem to use them - a notable difference compared to solutions that lock users into a single printer brand. 3D printing in dentistry has long moved beyond diagnostic models, and every new certified resin genuinely broadens the range of clinical applications for this technology, from surgery to prosthetics. For lab owners, this also means more freedom when planning investments in their equipment fleet.
02 · Artificial Intelligence
Harvard AI Aims to Help Dose Opioids More Precisely
A completely different direction of development is shown by a project from a team at Harvard School of Dental Medicine [2]. Researchers are working on an AI-based tool designed to help dentists choose opioid doses prescribed after surgical procedures. The system analyzes a specific patient's clinical, genetic, and social data, attempting to estimate as precisely as possible how much pain medication will actually be needed.
The goal is twofold: on one hand, to avoid undertreating pain, and on the other, to reduce the risk of overprescribing opioids, which has for years been one of the factors driving the opioid crisis in the United States. The tool isn't meant to stop working once the patient leaves the office - after the procedure, it would monitor the patient's condition and continuously adjust recommendations based on reported pain levels. This is a good example of how AI applications in dentistry don't have to stop at imaging diagnostics or treatment planning - they can just as easily extend to pharmacotherapy and patient safety.
03 · Periodontics
First At-Home Periodontal Dressing Cleared by the FDA
The third story this week is a change that could affect post-procedure care protocols in periodontics. Emanate Biomedical has received FDA clearance under the 510(k) pathway for Perio PODS [3] - the first periodontal dressing cleared by the U.S. agency for self-administered use at home.
The product takes the form of individually fitted gel trays that patients apply themselves twice a day for up to 15 days. It's intended for use after non-surgical procedures such as scaling and root planing, and its purpose is to protect healing periodontal tissue. This solution shifts part of periodontal care from the dental chair directly into the patient's home, which could genuinely ease the burden on follow-up appointment schedules and change how recovery after non-surgical procedures is planned.
Summary
Summary
Three news stories, one takeaway: the dental industry is advancing simultaneously on the level of materials, software, and patient care. Certified 3D printing resins, AI algorithms supporting clinical decisions, and new forms of at-home post-procedure care - this is just a taste of what awaits us in the coming months. If you want to see similar innovations live, test out equipment, and talk to manufacturers, join us at the Warsaw Dental Medica Show - International Dental and Aesthetic Medicine Trade Fair and Congress. It's the best place to stay up to date on what's actually making its way into dental practices.
Invitation
Certified 3D printing resins, AI supporting clinical decisions, and new periodontal care protocols - these are just some of what we'll be showcasing at the Warsaw Dental Medica Show. See the equipment and materials you're reading about in the news today live in action, talk to manufacturers, and find out what will actually make its way into your practice. Join us and stay one step ahead of the competition.
Warsaw Dental Medica Show 2026Footnotes
[1] 3D ADEPT Media — https://3dadept.com/ameralabs-launches-3-ce-class-i-materials-for-dental-3d-printing/[2] Dentonet.pl — https://dentonet.pl/lekarz/ai-pomoze-precyzyjniej-dobierac-opioidy-po-zabiegach-stomatologicznych
[3] GlobeNewswire — https://www.globenewswire.com/news-release/2026/09/17/3363966/0/en/emanate-receives-fda-510-k-clearance-for-perio-pods-the-first-fda-cleared-at-home-periodontal-wound-dressing-indicated-following-non-surgical-periodontal-procedures.html